Interleukin-6
The primary upstream cytokine triggering hepatic acute-phase protein synthesis.
Primary Biological Role: Pleiotropic cytokine that orchestrates systemic immune activation and directs hepatocytes to produce CRP and fibrinogen.
Evidence Score
Evidence Dimension Breakdown
Overview
Interleukin-6 (IL-6) sits directly upstream of C-Reactive Protein and represents one of the most mechanistically compelling inflammatory targets in modern medicine. Mendelian randomization of IL6R variants supports a causal role for IL-6 receptor signalling in coronary heart disease; CANTOS, an IL-1β trial, adds post-hoc evidence that lower on-treatment IL-6 tracks with fewer events. However, circulating IL-6 suffers from severe analytical challenges in routine clinical testing.
Biological Mechanism
Secreted by macrophages, endothelial cells, and T-cells in response to pathogen- or damage-associated molecular patterns (PAMPs/DAMPs). IL-6 signals through both classic membrane-bound IL-6 receptors (anti-inflammatory / regenerative) and trans-signaling via soluble IL-6 receptors (pro-inflammatory). Systemically, IL-6 binds hepatic receptors to directly induce transcription of acute-phase reactant genes.
Clinical Trial & Outcome Evidence
Strong causal evidence from human genetics (IL6R variant studies in Lancet 2012) and observational cohorts linking elevated basal IL-6 to all-cause mortality, frailty, and cardiovascular morbidity. CANTOS on-treatment analyses (PMID 30165610) provide proof-of-concept data that downstream IL-6 reduction correlates with reduced event rates.
Analytical Limitations & Confounders
Severe analytical limitations: circulating IL-6 has a short plasma half-life. IL-6 varies diurnally with a morning trough, so a morning fasting draw samples it at its daily low (Nilsonne 2016, PMID 27832117). In healthy adults, basal levels sit near the lower limit of quantitation (LLOQ) of commercial assays. Results vary significantly across immunoassay platforms (ELISA, ECLIA, Luminex), and no consensus clinical reference range or risk cut-point exists.
Kinetics & Retesting Frequency
IL-6 surges acutely following immune stimulation and clears rapidly once the stimulus resolves. For chronic low-grade wellness tracking, its rapid pulsatile kinetics create significant intra-individual noise on single blood draws.
Frequently Asked Questions
Why is IL-6 mechanistically superior to hs-CRP, but less reliable as a clinical blood test?
Mechanistically, IL-6 is the upstream trigger that forces the liver to make hs-CRP. However, as an analytical blood test, circulating IL-6 is plagued by a short half-life, lack of assay standardization between labs, diurnal fluctuation, and values near the detection floor in healthy individuals.
Can IL-6 be used to track wellness interventions?
Yes, but trend data must be interpreted cautiously. Because IL-6 is pulsatile and moves rapidly with exercise, circadian rhythms, and acute stress, multiple serial draws using the exact same laboratory platform are required.
Biomarker Profile
- Class
- Cytokine
- Score
- 60/100
- Grade
- C+
Key Published Studies
Related Biomarkers
Related Panel Patterns
Track Your Inflammation — Cohort Now Forming
Track your own inflammatory gene expression over time. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.